Reference
Institute for Clinical and Economic Review. ICER Publishes Final New Evidence Update for Alirocumab, a PCSK9 Inhibitor for Treating High Cholesterol. Internet Document : 15 Feb 2019. Available from: URL: https://icer-review.org/announcements/icer-publishes-final-new-evidence-update-for-alirocumab-a-pcsk9-inhibitor-for-treating-high-cholesterol/
Rights and permissions
About this article
Cite this article
ICER publishes final evidence update on alirocumab. PharmacoEcon Outcomes News 822, 37 (2019). https://doi.org/10.1007/s40274-019-5689-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5689-9